-
公开(公告)号:WO2020245175A1
公开(公告)日:2020-12-10
申请号:PCT/EP2020/065319
申请日:2020-06-03
IPC分类号: C07K14/705 , A61K39/00 , C07K16/28 , C12N15/62 , A61P35/00
摘要: The present invention relates to recombinant binding proteins comprising a designed ankyrin repeat domain with binding specificity for 4-1 BB (CD137). In addition, the invention relates to nucleic acids encoding such binding proteins, pharmaceutical compositions comprising such binding proteins or nucleic acids, and the use of such binding proteins, nucleic acids or pharmaceutical compositions in methods for activating 4-1 BB in cells expressing 4-1 BB, e.g., tumor-localized T-lymphocytes, and for treating or diagnosing diseases, such as cancer, in a mammal, including a human.
-
公开(公告)号:WO2020245746A1
公开(公告)日:2020-12-10
申请号:PCT/IB2020/055247
申请日:2020-06-03
IPC分类号: C07K14/435
摘要: This disclosure relates to multispecific recombinant proteins useful for the treatment of cancer.
-